Waters Corporation
Waters Corp. is a U.S.-based analytical instrument company organized around chromatography, mass spectrometry, thermal analysis, and related precision chemistry consumables and services. Through its Waters and TA operating segments, it serves laboratories in pharmaceutical, industrial, academic, and government settings worldwide.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueHPLC and UPLC instruments used to separate and analyze chemical mixtures.
MS instruments and workflow solutions for molecular identification and characterization.
Columns, reagents, and application-specific testing kits used with analytical instruments.
Installation, maintenance, training, and technical support for installed instruments.
TA systems for thermal analysis, rheometry, and calorimetry applications.
Products
Reported · share of revenue- Waters Instrument Systems34.8 %
- Waters Service34.1 %
- Chemistry Consumables19.9 %
- Ta Instrument Systems7.7 %
- Ta Service3.4 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Waters sells primarily to pharmaceutical companies, including large multinationals, generics, CROs, and biotech firms that need analytical tools for drug development, quality control, and regulated testing. It also serves industrial customers such as chemical, polymer, food and beverage, and environmental testing laboratories, plus universities and government agencies that buy instruments and services for research and compliance work.
Buy chromatography, mass spectrometry, consumables, and service for drug development, QC, and regulated testing.
Buy analytical systems for chemical, polymer, food, beverage, and environmental applications.
Buy instruments and service for research, teaching, and public-sector testing programs.
Buy advanced analytical workflows for outsourced and specialized life-science testing.
Strategy
Waters’ strategy centers on maintaining a strong installed base, expanding recurring revenue from consumables and service, and launching higher-value analytical workflows for advanced applications. The company also uses acquisitions and portfolio expansion to broaden its technology stack and address more end markets, while relying on direct sales and technical support to deepen customer relationships.
Consumables and service smooth demand and deepen customer lock-in around installed instruments.
Integrated LC/MS and TA workflows improve differentiation versus broader competitors.
Serving pharma, biotech, industrial, academic, and government customers reduces reliance on one demand pool.
Geography
Waters operates globally, with sales offices and field service coverage across major regions and a broad installed base supported by direct sales and service teams. The company’s disclosures show meaningful exposure to China and other international markets, while Europe and the Americas remain important demand centers for instruments, consumables, and service.
Risks
Waters faces cyclical demand tied to customer capital spending, especially in pharmaceuticals, academia, and government, where budgets can shift year to year. It also faces integration risk from acquisitions, foreign exchange and geopolitical exposure across its global footprint, and competitive pressure from larger diversified instrument makers.
- Integration risk from acquisitionsImpact: HighLikelihood: Medium
The company must combine new businesses, systems, and commercial teams without disrupting customer service or product development.
Exposure: BDS Business and prior acquisitions
- Cyclical instrument demandImpact: HighLikelihood: Medium
Many customers buy capital equipment from budgets that fluctuate with funding and spending cycles.
Exposure - Foreign currency and international exposureImpact: MediumLikelihood: Medium
A large share of sales and operations are outside the U.S., so translation and local demand shifts affect results.
Exposure - Competitive pressureImpact: MediumLikelihood: Medium
Competitors offer broader portfolios and may have greater financial resources and distribution.
Exposure: LC/MS and thermal analysis markets
Accounting
Judgemental itemsService contracts are billed in advance and instrument control may transfer at different times, affecting revenue timing.
Impact: Deferred revenue and quarterly comparability
Management estimates net realizable value based on demand, backlog, and market conditions.
Impact: Write-downs can affect gross margin and earnings
Acquisitions create large intangible balances that depend on future cash flow and discount-rate assumptions.
Impact: Potential non-cash impairment charges
Recent acquisitions require purchase accounting, fair value estimates, and integration-related allocations.
Impact: Amortization, asset step-ups, and acquisition-related charges
Similar listed companies
Publicly listed companies with a comparable business focus.
Veralto Corp
VLTO · Instruments For Meas & Testing of Electricity & Elec Signals
Veralto Corp is a U.S.-based industrial technology company focused on monitoring, protecting, and improving critical resources and processes.
Watts Water Technologies, Inc
WTS · Miscellaneous Fabricated Metal Products
Watts Water Technologies is a U.S.-based manufacturer of products and systems that manage the flow of water and energy in buildings.
Thermo Fisher Scientific Inc
TMO · Measuring & Controlling Devices, NEC
Thermo Fisher Scientific is a U.S.-based life sciences and laboratory company organized around four segments: Life Sciences Solutions, Analytical Instruments,…
Nephros, Inc
NEPH · Surgical & Medical Instruments & Apparatus
Quest Water Global, Inc.
QWTR · Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip
Ecolab Inc
ECL · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Ecolab makes water treatment, cleaning, sanitizing, and infection-prevention solutions used by industrial, food, healthcare, hospitality, and life sciences customers.
Last updated: 24/09/2026